Medicine Man Valuation
SHWZ Stock | USD 0.11 0.13 54.17% |
Medicine Man seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Medicine Man Technologies from analyzing the firm fundamentals such as Return On Equity of 0.16, profit margin of 0.15 %, and Current Valuation of 180.81 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medicine Man's price fluctuation is out of control at this time. Calculation of the real value of Medicine Man Technologies is based on 3 months time horizon. Increasing Medicine Man's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Medicine Man is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medicine Pink Sheet. However, Medicine Man's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.11 | Real 0.11 | Hype 0.11 | Naive 0.16 |
The intrinsic value of Medicine Man's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medicine Man's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medicine Man Technologies helps investors to forecast how Medicine pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medicine Man more accurately as focusing exclusively on Medicine Man's fundamentals will not take into account other important factors: Medicine Man Total Value Analysis
Medicine Man Technologies is at this time anticipated to have valuation of 180.81 M with market capitalization of 72.37 M, debt of 97.48 M, and cash on hands of 33.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Medicine Man fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
180.81 M | 72.37 M | 97.48 M | 33.86 M |
Medicine Man Investor Information
About 26.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medicine Man Technologies recorded a loss per share of 0.69. The entity had not issued any dividends in recent years. Based on the analysis of Medicine Man's profitability, liquidity, and operating efficiency, Medicine Man Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Medicine Man Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medicine Man has an asset utilization ratio of 38.04 percent. This suggests that the Company is making $0.38 for each dollar of assets. An increasing asset utilization means that Medicine Man Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Medicine Man Ownership Allocation
Medicine Man Technologies maintains a total of 54.74 Million outstanding shares. Medicine Man Technologies holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medicine Man Profitability Analysis
The company reported the previous year's revenue of 108.42 M. Net Income was 14.52 M with profit before overhead, payroll, taxes, and interest of 49.35 M.About Medicine Man Valuation
Our relative valuation model uses a comparative analysis of Medicine Man. We calculate exposure to Medicine Man's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medicine Man's related companies.Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. The company was incorporated in 2014 and is headquartered in Denver, Colorado. Medicine Man operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 389 people.
8 Steps to conduct Medicine Man's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medicine Man's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medicine Man's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medicine Man's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medicine Man's revenue streams: Identify Medicine Man's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medicine Man's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medicine Man's growth potential: Evaluate Medicine Man's management, business model, and growth potential.
- Determine Medicine Man's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medicine Man's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medicine Man Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 44.7 M | |
Quarterly Earnings Growth Y O Y | -0.991 | |
Retained Earnings | -27.8 M |
Additional Tools for Medicine Pink Sheet Analysis
When running Medicine Man's price analysis, check to measure Medicine Man's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicine Man is operating at the current time. Most of Medicine Man's value examination focuses on studying past and present price action to predict the probability of Medicine Man's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicine Man's price. Additionally, you may evaluate how the addition of Medicine Man to your portfolios can decrease your overall portfolio volatility.